免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

基礎-IQ技術

K 號:K193483 · 2020-02-28

決定日期2020-02-28
產品代碼QJS
諮詢委員會CH
決定相當於

器材摘要

Basal-IQ Technology is the device name listed in this FDA 510(k) record. The listed applicant is Tandem Diabetes Care, Inc.. It received FDA 510(k) clearance on 2020-02-28 under 510(k) number K193483. The device is classified under product code QJS. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Basal-IQ Technology?

Basal-IQ Technology is a medical device that received FDA 510(k) clearance on 2020-02-28. The listed applicant is Tandem Diabetes Care, Inc.. The 510(k) number is K193483.

When did Basal-IQ Technology receive FDA 510(k) clearance?

Basal-IQ Technology received FDA 510(k) clearance on 2020-02-28, under 510(k) number K193483.

Who is the listed applicant for Basal-IQ Technology?

The FDA 510(k) record lists Tandem Diabetes Care, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Basal-IQ Technology?

The FDA product code for Basal-IQ Technology is QJS.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Tandem Diabetes Care, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 18 項裝置 →

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑